The role of TET2 in the pathogenesis of MDS and its progression to AML-MR was investigated in this study, with emphasis on the gene expression of TET2, the presence or absence of pathogenic variants in TET2, and the potential effects of these two on the levels of 5-hmC in the DNA of the patients. This evidence concerns the gene TET2 and myelodysplastic syndrome.